Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

1200011I18Rik Inhibitors

Chemical inhibitors of 1200011I18Rik can exert their effects through various mechanisms by targeting specific signaling pathways and enzymes that are involved in the regulation and activity of this protein. Staurosporine, for example, is a potent inhibitor of protein kinases, which can prevent the phosphorylation of 1200011I18Rik, leading to its functional inhibition. This lack of phosphorylation prevents the activation of 1200011I18Rik or its ability to phosphorylate other substrates. Similarly, Bisindolylmaleimide I specifically targets Protein Kinase C, which, by inhibiting this kinase, reduces the phosphorylation and subsequent activation of 1200011I18Rik, leading to its inhibition. LY294002 and Wortmannin are both inhibitors of PI3K and by inhibiting this kinase, they can prevent the activation of the PI3K/Akt pathway, a crucial signaling route that may control the activity of 1200011I18Rik. Rapamycin inhibits mTOR, another key protein in cellular signaling, which can lead to the inhibition of 1200011I18Rik if it is regulated by mTOR-dependent pathways.

Further, PD98059 and U0126 are inhibitors of MEK, which is part of the MAPK/ERK pathway. By preventing the activation of this pathway, they can reduce the activity of 1200011I18Rik if it lies downstream. SB203580 acts on p38 MAPK, inhibiting the stress response pathway, which in turn could lead to the inhibition of 1200011I18Rik. SP600125 targets JNK, inhibiting this kinase and potentially leading to the inhibition of 1200011I18Rik if it is a downstream effector. Dasatinib and PP2 focus on Src family kinases, which when inhibited, can prevent the activation or function of 1200011I18Rik if it interacts with Src signaling. Lastly, Lapatinib inhibits EGFR/HER2 tyrosine kinases, which can lead to the inhibition of 1200011I18Rik by blocking the signaling pathways that may regulate or be regulated by this protein. Each of these chemicals acts to inhibit specific kinases or pathways, which in turn leads to the inhibition of 1200011I18Rik by preventing its activation, regulation, or interaction with other cellular components.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$92.00
$223.00
30
(1)

Another Src family kinase inhibitor which could inhibit the activation or function of 1200011I18Rik if it is associated with Src signaling.

Lapatinib

231277-92-2sc-353658
100 mg
$412.00
32
(1)

Inhibits EGFR/HER2 tyrosine kinases which could be involved in the regulation or downstream signaling affecting 1200011I18Rik activity.